NCT03816865View on ClinicalTrials.gov

Fibrosis, Inflammation and Brain Health in Atrial Fibrillation.

CompletedOBSERVATIONAL
Enrollment

46

Participants

Timeline

Start Date

March 1, 2018

Primary Completion Date

December 31, 2023

Study Completion Date

March 31, 2024

Conditions
Atrial FibrillationStroke
Trial Locations (2)

0424

Oslo University Hospital, Oslo

Unknown

Østfold Hospital, Sarpsborg

All Listed Sponsors
collaborator

Ostfold Hospital Trust

OTHER

lead

Oslo University Hospital

OTHER

NCT03816865 - Fibrosis, Inflammation and Brain Health in Atrial Fibrillation. | Biotech Hunter | Biotech Hunter